Observe Medical ASA
OOSL:OBSRV0.87
NOK
0.00
(0.00%)
ISIN
NO0013457952
Return %
Stock
S&P 500
1Y
25.76
14.20
3Y
-86.90
81.12
5Y
-98.81
68.34
Capital Structure
NOK
•
in mil. unless spec.Working Capital
NOK
•
in mil. unless spec.Growth Rates
NOK
•
in mil. unless spec.Semi-annual Revenue
NOK
•
in mil. unless spec.Semi-annual Earnings Per Share
NOK
•
in mil. unless spec.Semi-annual Dividends Per Share
NOK
•
in mil. unless spec.Company Description
- CEO
- Mann Jørgen
- Full Time Employees
- 5
- Sector
- Electronic technology
- Industry
- Electronic equipment/Instruments
- Address
- Oslo Norway
- IPO Date
- Nov 4, 2019
- Website
- observemedical.com
- Similar Companies
- Business
- Observe Medical ASA is a Nordic medical technology company that develops, manufactures, and markets clinical monitoring solutions and proprietary medtech devices designed for intensive care units, operating rooms, and specialized hospital departments. The company operates through a specialized product portfolio encompassing: the UnoMeter line of urine measurement and intra-abdominal pressure monitoring systems, including the UnoMeter Safeti Plus closed hourly diuresis system with KombiKon needle-free sampling ports to prevent retrograde urinary tract infections, UnoMeter Safeti Max extended-use diuresis meters, UnoMeter 500 hourly diuresis measurement units, and UnoMeter Abdo-Pressure monitoring kits; Sippi, an automated digital urine measurement system utilizing contactless capacitance sensors and patented Sippcoat silicone oil technology to inhibit bacterial biofilm formation and reduce catheter-associated infections; Biim, a portable, wireless point-of-care ultrasound probe engineered for procedural guidance in vascular access, catheterization, and dialysis treatments; and an array of complementary sterile closed-system drainage bags, front-mounted meters, and single-use urological consumables. Founded in 2019 following a demerger from Navamedic ASA and headquartered in Oslo, Norway, the company conducts research, development, and regulatory affairs primarily via its Swedish operations in Gothenburg. Observe Medical serves healthcare systems and hospital networks through a direct sales organization across the Nordic region and an international distribution network spanning more than 35 countries throughout Europe, the United Kingdom, and Asia. In recent operational developments, Observe Medical acquired the global UnoMeter and Abdo-Pressure product assets from Unomedical A/S, a subsidiary of Convatec Group Plc, to secure worldwide trademark and intellectual property rights. The company subsequently established a high-volume manufacturing platform in partnership with Jiangsu Hongxin Medical Technology Co., Ltd., finalized its Declaration of Conformity to resume scalable production of the UnoMeter 500 and UnoMeter Safeti Plus lines, and initiated preparations for the integrated UnoMeter Sippi diuresis system. Commercially, Observe Medical expanded its global presence by securing an exclusive distribution agreement and a regional public tender award in Italy, establishing an exclusive distribution agreement in India, initiating German commercialization via Siramo GmbH, and supplying the UK National Health Service through an NHS Supply Chain framework agreement. To support commercial expansion, manufacturing ramp-up, and regulatory initiatives, Observe Medical completed equity financing rounds through private placements and subsequent share offerings, entered into an investment agreement with Songa Capital AS, and secured a NOK 15 million loan facility from Innovation Norway.